Skip to main content
GoodMoatv1.3
Sign in
AZN logo

AZN

CompareEarnings: Aug 31, 2026

Astrazeneca plc

Exchange: NASDAQSector: HealthcareIndustry: Drug Manufacturers - General

AstraZeneca (LSE/STO/Nasdaq: AZN ) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca.

Did you know?

Pays a 1.73% dividend yield.

Current Price

$184.74

-1.40%

GoodMoat Value

$228.37

23.6% undervalued
Profile
Valuation (TTM)
Market Cap$286.51B
P/E27.58
EV—
P/B5.89
Shares Out1.55B
P/Sales4.74
Revenue$60.44B
EV/EBITDA15.28

Astrazeneca plc (AZN) Company Profile

AZN Company Information

AstraZeneca (LSE/STO/Nasdaq: AZN ) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.

Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.

com and follow the Company on social media @AstraZeneca.

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NASDAQ

Country

United Kingdom

AZN Key Officers

Key officers data coming soon

AZN Company Profile

Astrazeneca plc (AZN) is a Healthcare company in the Drug Manufacturers - General industry. It trades on NASDAQ. The company is based in United Kingdom.

AstraZeneca (LSE/STO/Nasdaq: AZN ) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca.

Market cap is $286.51B. There are 1550.9M shares outstanding. Dividend yield is 1.73%.

See the full Astrazeneca plc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if AZN is a good investment.